Grifols Insider Trading Activity | NASDAQ:GRFS

Comments

Grifols SA Insider Trading Activity

GRFSNASDAQ

Trade with Public

$8.39

0.293.58%

At close: Apr 7, 5:00 PM EST

$8.20

0.11.23%

Pre-Market: 8:48 AM EST

Overview News Earnings Options Guidance Dividends Analyst Ratings Short Interest Government Trades Stock Report

Grifols Insider Trading Activity | NASDAQ:GRFS | Benzinga

Track the latest Grifols insider trading activity. Stay informed on recent buys, sells, and market impact for Grifols stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Grifols SA Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for Grifols SA

Shares Outstanding

680.509M

Institutional Shares Held

72.291M

Institutional Percentage Held

10.6%

Loading calendar...

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

GRFS Insider Trading News

Grifols Announced Strategic Investment from GIC of $1B

Grifols (NASDAQ: GRFS) and GIC, the sovereign wealth fund of Singapore, have entered into a definitive agreement under which GIC will invest ~USD 1 billion in Grifols' wholly owned US subsidiary Biomat USA.

Charles Gross

People Also Watch

Immunovant Inc

NASDAQ:IMVT

$24.73

Cogent Biosciences Inc

Centessa Pharmaceuticals PLC

NASDAQ:CNTA

$39.53

Xenon Pharmaceuticals Inc

Protagonist Therapeutics Inc